Atropine, 0.01%, for Myopia Control

被引：5
|
作者：
Walline, Jeffrey J. J. [1 ]
Berntsen, David A. A. [2 ]
机构：
[1] Ohio State Univ, Coll Optometry, 338 W Tenth Ave, Columbus, OH 43210 USA
[2] Univ Houston, Coll Optometry, Houston, TX USA
来源：
JAMA OPHTHALMOLOGY | 2023年 / 141卷 / 08期
关键词：
D O I：
10.1001/jamaophthalmol.2023.3076
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：766 / 767
页数：2
相关论文
共 50 条
  • [1] Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful?
    Khanal, Safal
    Phillips, John R.
    JAMA OPHTHALMOLOGY, 2024, 142 (03)
  • [2] Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful?-Reply
    Zadnik, Karla
    Flitcroft, Ian
    Hemmati, Houman D.
    JAMA OPHTHALMOLOGY, 2024, 142 (03) : 272 - 272
  • [3] Does 0.01% atropine have a place as a myopia control therapy?
    Phillips, John R.
    Yam, Jason C.
    Khanal, Safal
    OPHTHALMIC AND PHYSIOLOGICAL OPTICS, 2025,
  • [4] Effect of atropine 0.01% on progression of myopia
    Sen, Snigdha
    Yadav, Himanshu
    Jain, Anu
    Verma, Sadhna
    Gupta, Preeti
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (09) : 3373 - 3376
  • [5] Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2 Myopia Control with Atropine 0.01% Eyedrops
    Chia, Audrey
    Lu, Qing-Shu
    Tan, Donald
    OPHTHALMOLOGY, 2016, 123 (02) : 391 - 399
  • [6] Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
    Zhang, Xiaoyu
    Wang, Yuliang
    Zhou, Xingtao
    Qu, Xiaomei
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [7] Change in pupil size with atropine 0.01% is not associated with myopia control efficacy
    Dadzie, Emmanuella Esi
    Kobia-Acquah, Emmanuel
    Flitcroft, Ian
    Biba, Matilda
    Loughman, James
    Lingham, Gareth
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [8] Pan-Indian multicentre retrospective study of 0.01% atropine for myopia control
    Yam, Jason C.
    Zhang, Yuzhou
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2024, 108 (04) : 493 - 494
  • [9] Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
    Luyao Ye
    Hannan Xu
    Ya Shi
    Yao Yin
    Tao Yu
    Yajun Peng
    Shanshan Li
    Jiangnan He
    Jianfeng Zhu
    Xun Xu
    Ophthalmology and Therapy, 2022, 11 : 2197 - 2210
  • [10] Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
    Ye, Luyao
    Xu, Hannan
    Shi, Ya
    Yin, Yao
    Yu, Tao
    Peng, Yajun
    Li, Shanshan
    He, Jiangnan
    Zhu, Jianfeng
    Xu, Xun
    OPHTHALMOLOGY AND THERAPY, 2022, 11 (06) : 2197 - 2210
12345